Hemato-oncology  

New Molecular Approaches in DLBCL

Dr Brian T. Hill discusses New Molecular Approaches in Diffuse Large B-Cell Lymphoma (DLBCL)

Dr Brian Hill

Dr Brian Hill
Publication Date

Sep 2021

info Summary and next episodes download Downloadable resources

Watch the video and download the slides

Dr Hill is the Director of the Lymphoid Malignancies Program and a Staff Physician in the Cleveland Clinic Taussig Cancer Institute.  He received his undergraduate degree from Dartmouth College and earned his Ph.D. in genetics through work done at Cold Spring Harbor Laboratory.  He received his medical degree from the University of Chicago Pritzker School of Medicine where he also completed his residency in Internal Medicine.  He completed his hematology/oncology fellowship at the Cleveland Clinic.   His clinical and research focus is in chronic lymphocytic leukemia (CLL) and lymphoma.  He is the principal investigator of multiple on-going clinical trials of new cancer treatments including novel cellular therapies

Dr Brian Hill has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Abbvie, AstraZeneca, Genetech, Gilead and Pharmacyclics
Programme summary
Watch the video now
Share this programme
x-twitter
This educational programme is supported by an Independent Educational Grant from Bayer
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Bayer
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
LYMPHOMA & MYELOMA CONNECT

LYMPHOMA & MYELOMA CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer, Karyopharm Therapeutics and Menarini Stemline Oncology.

Meet the experts Independent IME approved

Other programmes of interest

eks
EKS / On-demand webinar
Oncology Hemato-oncology 
Multiple Myeloma: Is it time to rethink how we sequence treatments?

On-demand materials from an Experts Knowledge Share event

Experts
Prof. Karthik Ramasamy, Dr Joshua Richter, Dr Faisal Basheer, Dr Andrew Charlton
  • download Downloadable
    Resources
  • clock 80 MIN
  • calendar Mar 2026
COR2ED
This programme has been sponsored by Menarini Stemline and is intended for HCPs in the UK only    MAT-GB-SEL-00774
patient-support Patient Support
Oncology Hemato-oncology Pediatrics 
Personalised treatment in childhood cancer: A journey through NTRK fusion testing

Experts
Linet Menachery
Endorsed by
NTRKers ICAN international cancer advocacy network Biomarker Collaborative
  • clock 4 MIN
  • calendar Mar 2026
  • Non-accredited Independent Medical Education
PRECISION ONCOLOGY CONNECT
Educational programme supported by an Independent Educational Grant from Bayer.
eks
EKS / On-demand webinar
Oncology Hemato-oncology 
Optimising the management of multiple myeloma in the early relapsed/refractory setting (RRMM)

Medical experts discuss the latest learnings from clinical practice

Experts
Prof. Aurore Perrot, Prof. Hermann Einsele, Prof. Karthik Ramasamy, Dr Joshua Richter
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Jun 2024
  • Non-accredited Independent Medical Education
LYMPHOMA & MYELOMA CONNECT
Educational programme supported by an Independent Educational Grant from Menarini Stemline Oncology.
Explore all programmes